These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21806380)

  • 1. Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.
    Ghosh AK; Anderson DD
    Future Med Chem; 2011 Jul; 3(9):1181-97. PubMed ID: 21806380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors.
    Ghosh AK; Thompson WJ; McKee SP; Duong TT; Lyle TA; Chen JC; Darke PL; Zugay JA; Emini EA; Schleif WA
    J Med Chem; 1993 Jan; 36(2):292-4. PubMed ID: 8423600
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants.
    Ghosh AK; Rao KV; Nyalapatla PR; Osswald HL; Martyr CD; Aoki M; Hayashi H; Agniswamy J; Wang YF; Bulut H; Das D; Weber IT; Mitsuya H
    J Med Chem; 2017 May; 60(10):4267-4278. PubMed ID: 28418652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-peptidic HIV protease inhibitors.
    Chrusciel RA; Strohbach JW
    Curr Top Med Chem; 2004; 4(10):1097-114. PubMed ID: 15193141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Photochemical Route to Optically Active Hexahydro-4
    Ghosh AK; Robinson WL
    J Org Chem; 2019 Aug; 84(15):9801-9805. PubMed ID: 31310117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterocyclic HIV-protease inhibitors.
    Calugi C; Guarna A; Trabocchi A
    Curr Med Chem; 2013; 20(30):3693-710. PubMed ID: 23746271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation and X-ray structural studies of HIV-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligands.
    Ghosh AK; Martyr CD; Kassekert LA; Nyalapatla PR; Steffey M; Agniswamy J; Wang YF; Weber IT; Amano M; Mitsuya H
    Org Biomol Chem; 2015 Dec; 13(48):11607-21. PubMed ID: 26462551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir.
    Aoki M; Hayashi H; Yedidi RS; Martyr CD; Takamatsu Y; Aoki-Ogata H; Nakamura T; Nakata H; Das D; Yamagata Y; Ghosh AK; Mitsuya H
    J Virol; 2015 Nov; 90(5):2180-94. PubMed ID: 26581995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
    Rusere LN; Lockbaum GJ; Henes M; Lee SK; Spielvogel E; Rao DN; Kosovrasti K; Nalivaika EA; Swanstrom R; Kurt Yilmaz N; Schiffer CA; Ali A
    J Med Chem; 2020 Aug; 63(15):8296-8313. PubMed ID: 32672965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20.
    Agniswamy J; Louis JM; Shen CH; Yashchuk S; Ghosh AK; Weber IT
    J Med Chem; 2015 Jun; 58(12):5088-95. PubMed ID: 26010498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.
    Ghosh AK; Osswald HL; Prato G
    J Med Chem; 2016 Jun; 59(11):5172-208. PubMed ID: 26799988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex.
    Oscarsson K; Lahmann M; Lindberg J; Kangasmetsä J; Unge T; Oscarson S; Hallberg A; Samuelsson B
    Bioorg Med Chem; 2003 Mar; 11(6):1107-15. PubMed ID: 12614898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance.
    Ghosh AK; Ramu Sridhar P; Kumaragurubaran N; Koh Y; Weber IT; Mitsuya H
    ChemMedChem; 2006 Sep; 1(9):939-50. PubMed ID: 16927344
    [No Abstract]   [Full Text] [Related]  

  • 16. [The newest developments in anti-HIV-1 drugs].
    Zhang XQ
    Yao Xue Xue Bao; 2010 Feb; 45(2):194-204. PubMed ID: 21351429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Structure-activity studies and biological evaluation.
    Bai X; Yang Z; Zhu M; Dong B; Zhou L; Zhang G; Wang J; Wang Y
    Eur J Med Chem; 2017 Sep; 137():30-44. PubMed ID: 28554091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.
    Agniswamy J; Shen CH; Wang YF; Ghosh AK; Rao KV; Xu CX; Sayer JM; Louis JM; Weber IT
    J Med Chem; 2013 May; 56(10):4017-27. PubMed ID: 23590295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.
    Whiting M; Tripp JC; Lin YC; Lindstrom W; Olson AJ; Elder JH; Sharpless KB; Fokin VV
    J Med Chem; 2006 Dec; 49(26):7697-710. PubMed ID: 17181152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments of peptidomimetic HIV-1 protease inhibitors.
    Qiu X; Liu ZP
    Curr Med Chem; 2011; 18(29):4513-37. PubMed ID: 21864279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.